Mobile Old Site Home Daily Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:50:13 EDT Thu 20 Sep 2018
Enter Symbol
or Name
USA
CA



Q:GILD - Gilead Sciences, Inc. - http://www.gilead.com04:50:13 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
GILD - Q0.173.80 · 73.950.573.88+0.210.33,662.9270,80826,22973.47  74.32  73.3089.54  64.27Sep 19 19:19:33Sep 1215 min RT 2¢

Recent Trades - Last 10 of 26229
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2018-09-12 08:31U:GILDNews ReleaseGilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing
2018-09-11 16:05U:GILDNews ReleaseGilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints in First Phase 3 Study in Rheumatoid Arthritis
2018-09-06 01:00U:GILDNews ReleaseGilead and Galapagos Announce TORTUGA Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint
2018-09-04 16:05U:GILDNews ReleaseGilead Enters Licensing Agreement With Trianni for Use of Trianni Transgenic Human Monoclonal Antibody Discovery Platform
2018-08-30 16:01U:GILDNews ReleaseGilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12
2018-08-28 17:00U:GILDNews ReleaseGilead Sciences Appoints Laura Hamill as Executive Vice President, Worldwide Commercial Operations
2018-08-27 06:34U:GILDNews ReleaseYescarta ® (Axicabtagene Ciloleucel) Receives European Marketing Authorization for the Treatment of Relapsed or Refractory DLBCL and PMBCL, After Two or More Lines of Systemic Therapy